Results 151 to 160 of about 18,578 (279)

Epstein-Barr virus-associated autoimmune hemolytic anemia: a clinical report and review of literature. [PDF]

open access: yesItal J Pediatr
Accomando S   +5 more
europepmc   +1 more source

A New Property of Iso-Agglutinins of the ABO Blood Group System [PDF]

open access: bronze, 1959
Alan Richardson Jones, Lorraine Kaneb
openalex   +1 more source

A case of depression with psychotic features associated with hemoglobin Manukau mutation

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 4, Issue 3, September 2025.
Abstract Background It is pertinent to investigate organic possibilities in acute presentation of mental illness. Iron‐deficiency anemia has long been established to cause symptoms of major depressive disorder. The association between depression and hemolytic anemia and hemochromatosis is less understood.
Zhonghao Zhang   +5 more
wiley   +1 more source

Stickiness of Erythrocytes Caused by Certain Agglutinins [PDF]

open access: bronze, 1959
William C. Boyd, Marjorie H. McMaster
openalex   +1 more source

Mixed Autoimmune Hemolytic Anemia: A Systematic Review of Epidemiology, Clinical Characteristics, Therapies, and Outcomes

open access: yesAmerican Journal of Hematology, Volume 100, Issue 8, Page 1397-1407, August 2025.
Mixed autoimmune hemolytic anemia (AIHA) is a rare condition characterized by the presence of both warm and cold autoantibodies, often leading to severe, treatment‐resistant hemolysis. In this systematic review of 81 patients across 35 studies, the median age was 45 years with a notable female predominance.
Jeremy W. Jacobs   +12 more
wiley   +1 more source

Confirmation of Fixed Quarterly Riliprubart Regimen in Patients with Cold Agglutinin Disease Using Population PK/PD and Exposure‐Response Analyses

open access: yesClinical Pharmacology &Therapeutics, Volume 118, Issue 2, Page 449-458, August 2025.
Riliprubart is a second‐generation, humanized immunoglobulin G4 that inhibits only the activated form of the C1s component of the proximal classical complement pathway. The clinical studies of riliprubart conducted thus far for the treatment of cold agglutinin disease (CAD), a rare autoimmune disease, include a Phase 1 first‐in‐human study in healthy ...
Timothy Chow   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy